Aktis Insider Trades Signal Confidence: How Executive Moves Highlight 225Ac Oncology Potential
Aktis Oncology insider trading shows exec confidence in its 225Ac radiopharma pipeline, revealing a “buy low, sell high” strategy that signals growth prospects and liquidity tactics for biotech investors.
4 minutes to read